GenMont Biotech Financials
| 3164 Stock | TWD 20.05 0.10 0.50% |
GenMont |
Understanding current and past GenMont Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of GenMont Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in GenMont Biotech's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in GenMont Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of GenMont Biotech. Check GenMont Biotech's Beneish M Score to see the likelihood of GenMont Biotech's management manipulating its earnings.
GenMont Biotech Stock Summary
GenMont Biotech competes with Voltronic Power, Galaxy Software, Sunnic Technology, Golden Biotechnology, and Avalue Technology. GenMont Biotech Incorporation engages in the research, development, and production of functional probiotics in Taiwan. The company was founded in 2000 and is based in Tainan, Taiwan. GENMONT BIOTECH operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan Stock Exchange |
| ISIN | TW0003164000 |
| Business Address | No8, Nanke 7th |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.genmont.com.tw |
| Phone | 886 8 0080 0980 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in GenMont Biotech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of GenMont Stock, because this is throwing your money away. Analyzing the key information contained in GenMont Biotech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
GenMont Biotech Key Financial Ratios
There are many critical financial ratios that GenMont Biotech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that GenMont Biotech reports annually and quarterly.| Return On Equity | 0.0535 | |||
| Return On Asset | 0.0289 | |||
| Target Price | 102.0 | |||
| Number Of Employees | 13 | |||
| Beta | 0.34 |
GenMont Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GenMont Biotech's current stock value. Our valuation model uses many indicators to compare GenMont Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GenMont Biotech competition to find correlations between indicators driving GenMont Biotech's intrinsic value. More Info.GenMont Biotech is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.54 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for GenMont Biotech is roughly 1.85 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GenMont Biotech's earnings, one of the primary drivers of an investment's value.GenMont Biotech Systematic Risk
GenMont Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. GenMont Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on GenMont Biotech correlated with the market. If Beta is less than 0 GenMont Biotech generally moves in the opposite direction as compared to the market. If GenMont Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one GenMont Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of GenMont Biotech is generally in the same direction as the market. If Beta > 1 GenMont Biotech moves generally in the same direction as, but more than the movement of the benchmark.
GenMont Biotech November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of GenMont Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of GenMont Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of GenMont Biotech based on widely used predictive technical indicators. In general, we focus on analyzing GenMont Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GenMont Biotech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.35) | |||
| Maximum Drawdown | 4.87 | |||
| Value At Risk | (1.83) | |||
| Potential Upside | 1.32 |
Additional Tools for GenMont Stock Analysis
When running GenMont Biotech's price analysis, check to measure GenMont Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GenMont Biotech is operating at the current time. Most of GenMont Biotech's value examination focuses on studying past and present price action to predict the probability of GenMont Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GenMont Biotech's price. Additionally, you may evaluate how the addition of GenMont Biotech to your portfolios can decrease your overall portfolio volatility.